Other products achieving annual net sales of more than USD 1 billion were Zometa (USD 1.4 billion) as well as Femara and Sandostatin (each USD 1.1 billion).
Trois autres produits – Zometa (USD 1,4 milliard), Femara et Sandostatine (USD 1,1 milliard chacun) – ont affiché un chiffre d’affaires net supérieur à USD 1 milliard.